Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies
Authors:
Top Cited Papers
Open Access
- 17 February 2023
- journal article
- review article
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 8 (1) , 1-40
Abstract
Hematologic malignancies are one of the most common cancers, and the incidence has been rising in recent decades. The clinical and molecular features of hematologic malignancies are highly heterogenous, and some hematologic malignancies are incurable, challenging the treatment, and prognosis of the patients. However, hematopoiesis and oncogenesis of hematologic malignancies are profoundly affected by epigenetic regulation. Studies have found that methylation-related mutations, abnormal methylation profiles of DNA, and abnormal histone deacetylase expression are recurrent in leukemia and lymphoma. Furthermore, the hypomethylating agents and histone deacetylase inhibitors are effective to treat acute myeloid leukemia and T-cell lymphomas, indicating that epigenetic regulation is indispensable to hematologic oncogenesis. Epigenetic regulation mainly includes DNA modifications, histone modifications, and noncoding RNA-mediated targeting, and regulates various DNA-based processes. This review presents the role of writers, readers, and erasers of DNA methylation and histone methylation, and acetylation in hematologic malignancies. In addition, this review provides the influence of microRNAs and long noncoding RNAs on hematologic malignancies. Furthermore, the implication of epigenetic regulation in targeted treatment is discussed. This review comprehensively presents the change and function of each epigenetic regulator in normal and oncogenic hematopoiesis and provides innovative epigenetic-targeted treatment in clinical practice.Keywords
This publication has 790 references indexed in Scilit:
- MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon AdenocarcinomaJAMA, 2008
- Microrna expression distinguishes between germinal center B cell‐like and activated B cell‐like subtypes of diffuse large B cell lymphomaInternational Journal of Cancer, 2007
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- The Epigenomics of CancerCell, 2007
- Histone Methylation-Dependent Mechanisms Impose Ligand Dependency for Gene Activation by Nuclear ReceptorsCell, 2007
- BIC and miR‐155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomasThe Journal of Pathology, 2005
- Targeted mutation of the DNA methyltransferase gene results in embryonic lethalityCell, 1992
- Identification of a mammalian protein that binds specifically to DNA containing methylated CpGsCell, 1989
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987
- A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNACell, 1985